GlassScriptPhysician profile
Rachel C Jankowitz
NPI 1104027218
$3,838.33
in general payments reported to CMS, 2019-2025
9 companies · $491 in 2025
The $491 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,746 · 2020: $97.21 · 2021: $11.92 · 2022: $340 · 2023: $1,153 · 2025: $491.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $769 · Food and Beverage: $703 · Travel and Lodging: $173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $768.60 |
| Food and Beverage | $702.50 |
| Travel and Lodging | $172.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $1,500.00 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $1,012.85 | 2022-2025 | |
| Pfizer INC. | $461.49 | 2019-2022 | |
| Gilead Sciences, INC. | $254.57 | 2021-2023 | Trodelvy |
| Stryker Corporation | $199.89 | 2025 | Molli, Spy-Phi System |
| Medtronic, INC. | $149.57 | 2022 | |
| Novartis Pharmaceuticals Corporation | $137.07 | 2025 | |
| Stemline Therapeutics INC. | $122.89 | 2023 | Orserdu |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Jankowitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.